Hydroxyurea Use in Young Children With Sickle Cell Anemia in New York State-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hydroxyurea Use in Young Children With Sickle Cell Anemia in New York State

Published:2016-07 Issue:1 Volume:51 Page:S31-S38
ISSN:0749-3797
Container-title:American Journal of Preventive Medicine
language:en
Short-container-title:American Journal of Preventive Medicine

Author:

Anders David G.,Tang Fei,Ledneva Tatania,Caggana Michele,Green Nancy S.,Wang Ying,Sturman Lawrence S.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Epidemiology

Reference33 articles.

1. Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea;Charache;Control Clin Trials,1995

2. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up;Steinberg;Am J Hematol,2010

3. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment;Steinberg;JAMA,2003

4. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS);Voskaridou;Blood,2010

5. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial;Ferster;Blood,1996

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy‐based refill records;Pediatric Blood & Cancer;2024-07-08

2. Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)—A randomized, placebo‐controlled phase II feasibility/pilot study;American Journal of Hematology;2024-07-02

3. High hydroxyurea usage in sickle cell anemia regardless of patient demographics;Pediatric Blood & Cancer;2023-12-09

4. Case Ascertainment of Sickle Cell Disease Using Surveillance or Single Administrative Database Case Definitions;Public Health Reports;2023-05-19

5. Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia;Pediatric Blood & Cancer;2023-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3